MEC Plus

Hepatocellular and Biliary Cancers: Recent advances
Hepatocellular and Biliary Cancers: Recent advances
Anthony El-Khoueiry, MD
Renal Cell Cancer: Recent Advances
Renal Cell Cancer: Recent Advances
Primo N. Lara, Jr., MD
Castration Resistant Prostate Cancer: What is the Optimal Treatment?
Castration Resistant Prostate Cancer: What is the Optimal Treatment?
Sarmad Sadeghi, MD, PhD
State of the Art: Hormone-sensitive Prostate Cancer
State of the Art: Hormone-sensitive Prostate Cancer
Primo N. Lara, Jr., MD
Advance in Treatment of Acute Lymphocyctic Leukemia
Advance in Treatment of Acute Lymphocyctic Leukemia
George Yaghmour, MD
Lymphoma: State of the Art
Lymphoma: State of the Art
Joseph M. Tuscano, MD
Lymphoma: State of the Art
Lymphoma: State of the Art
Joseph M. Tuscano, MD
AML and MDS: Current Status and Future Directions
AML and MDS: Current Status and Future Directions
Brian A. Jonas, MD, PhD, FACP
The Future of Combined Modality Therapy
The Future of Combined Modality Therapy
Everett E. Vokes, MD
Updates in Treatment of Early Stage and Locally Advanced NSCLC
Updates in Treatment of Early Stage and Locally Advanced NSCLC
Erminia Massarelli, MD, PhD, MS
Advances in Small Cell Lung Cancer and Mesothelioma
Advances in Small Cell Lung Cancer and Mesothelioma
Ravi Salgia, MD, PhD
Updates in Targeted Therapy for NSCLC
Updates in Targeted Therapy for NSCLC
Jonathan W. Riess, MD. MS